Browse by Medical Category
Talk to an access nurse today
The Claire & John Bertucci Center for Genitourinary Cancers is one of the largest and most experienced centers in New England for the diagnosis and treatment of prostate cancer. Many of the diagnostic and therapeutic approaches available here are offered at only a few centers nationwide.
Our unique approaches to prostate cancer treatment include:
New patients are generally seen within two weeks of referral. We will work with you to develop a treatment plan that balances potential treatment side effects and benefits. We will continue to monitor your care and communicate regularly with you and your referring physician about your progress.
Exact diagnosis and staging are critical to defining the appropriate treatment for your cancer, including establishing whether you are a candidate for active surveillance. Your team will include sub-specialized pathologists, who work exclusively on analyzing genitourinary tumors, and whose training and experience help ensure your treatment plan is based on a precise diagnosis. Our pathologists perform a Gleason score analysis of every prostate tumor to assess the likelihood of tumor spread.
In addition to using the standard imaging techniques, we are conducting clinical trials on the use of novel techniques to diagnose and stage prostate cancer. These include:
Studies have shown patients do better when they are treated in a facility that cares for a high number of patients with the same form of cancer; we perform a large number of prostate cancer diagnostic and treatment procedures annually.
In addition to being skilled at conventional surgery, our genitourinary cancer surgeons are at the forefront of developing minimally invasive approaches for the treatment of prostate cancer, including both laparoscopic and robotic prostatectomy.
Depending on the size of your prostate and the location of your cancer, you may receive internal radiation (brachytherapy) or external radiation. External radiation is delivered using advanced 3-dimensional (3-D) or intensity modulated (IMRT) radiation techniques. The prostate is targeted using daily imaging to precisely direct the radiation beam. As one of only a few centers nationwide offering proton beam radiation, we are working to understand its correct place in the treatment of prostate cancer.
Learn more about radiation therapy
New patients are generally seen within a week of referral. At your first appointment, you will meet the genitourinary cancer specialists who will be involved in your care, including:
In addition, you may also see:
Matthew R. Smith, MD, PhDDirector, Genitourinary Malignancies Program
The prostate is a small, round gland located behind the pubic bone and in front of the rectum. Cancer that begins in the tissues of the prostate is called prostate cancer.
The American Cancer Society (ACS) estimates that about 220,800 new cases of prostate cancer would be diagnosed in the United States in 2015, and that the disease would cause about 27,540 deaths.
Screening for cancer means testing for something abnormal before it makes you sick. Tests used to screen for prostate cancer include:
If the DRE or PSA test raises possible concerns, your doctor may also order tests and procedures such as:
Treatment for early-stage prostate cancer may involve one or more of these options:
Treatment for metastatic prostate cancer may involve one or more of these options:
Clinical trials are research studies of new drugs, new combinations of drugs or already approved drugs being studied to treat patients in new/different ways. They may include new drug doses or new ways (schedules) to give the drugs. Clinical trials are run under strict guidelines. Their purpose is to help find out whether new cancer treatments are safe and effective or better than the standard (current) treatment. At Massachusetts General Hospital Cancer Center, there are several clinical trials open for the treatment of prostate cancer that use the latest in cancer treatments.
Cancer is increasingly becoming a disease in which the genetic makeup of each individual cancer drives therapy. The Center for Genitourinary Cancers also has access to clinical trials involving these targeted therapy approaches.
The Cancer Center also offers the Lazarex-MGH Cancer Care Equity Program, which strives to promote awareness about and access to cancer clinical trials through community outreach and education, financial assistance, and patient navigation. Learn more about this program.
If you have any questions or would like to speak with one of our doctors, please call the Claire and John Bertucci Center for Genitourinary Cancers at 617-724-4000.
Back to Top